Verition Fund Management
STRO icon

Verition Fund Management’s Sutro Biopharma STRO Stock Holding History

Verition Fund Management’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-9,789
Closed -$287K – 3503
2024
Q2 		$287K Sell
9,789
-18,573
-65% -$734K ﹤0.01% 2379
2024
Q1 		$1.6M Sell
28,362
-33,925
-54% -$1.5M 0.01% 1342
2023
Q4 		$2.67M Sell
62,287
-187,881
-75% -$5.96M 0.02% 702
2023
Q3 		$8.68M Buy
250,168
+55,502
+29% +$2.42M 0.1% 262
2023
Q2 		$9.05M Buy
194,666
+80,087
+70% +$3.99M 0.12% 227
2023
Q1 		$5.29M Sell
114,579
-45,844
-29% -$2.91M 0.07% 350
2022
Q4 		$13M Buy
160,423
+35,012
+28% +$2.43M 0.2% 112
2022
Q3 		$6.96M Buy
125,411
+52,903
+73% +$3.13M 0.08% 295
2022
Q2 		$3.78M Buy
+72,508
New +$4.05M 0.07% 363
2022
Q1 		– Sell
-18,477
Closed -$2.75M – 3016
2021
Q4 		$2.75M Buy
18,477
+2,176
+13% +$390K 0.02% 679
2021
Q3 		$3.08M Buy
16,301
+5,869
+56% +$1.12M 0.03% 427
2021
Q2 		$1.94M Sell
10,432
-36,701
-78% -$7.18M 0.02% 543
2021
Q1 		$10.7M Buy
47,133
+14,556
+45% +$3.45M 0.12% 111
2020
Q4 		$7.07M Buy
32,577
+12,007
+58% +$1.99M 0.06% 167
2020
Q3 		$2.07M Buy
+20,570
New +$1.94M 0.04% 247

Other funds holding STRO

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Verition Fund Management's STRO Position: Q3 2024 in Review

Verition Fund Management sold out of Sutro Biopharma (STRO) in Q3 2024, closing a stake of 9,789 shares — an estimated $287K sold.

Verition Fund Management first reported a position in STRO in Q3 2020 and held it in 15 quarters. The position peaked at $13M in Q4 2022. 130 funds tracked by Wall St. Rank hold STRO as of Q3 2024.

  • Verition Fund Management reported no remaining Sutro Biopharma position as of Q3 2024 after selling out during the quarter.
  • Verition Fund Management sold 9,789 Sutro Biopharma shares in Q3 2024, an estimated $287K.
  • Verition Fund Management first reported a position in Sutro Biopharma in Q3 2020 and held it in 15 quarters.
  • Verition Fund Management's Sutro Biopharma position peaked at $13M in Q4 2022.
  • 130 funds tracked by Wall St. Rank held Sutro Biopharma as of Q3 2024.

Based on Verition Fund Management's 13F filing for Q3 2024, filed 14 Nov 2024.